About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 745943, 8 pages
http://dx.doi.org/10.1155/2013/745943
Research Article

Coefficient of Energy Balance: Effective Tool for Early Differential Diagnosis of CNS Diseases

1Department of Clinical Biochemistry, Thomayer’s Hospital, Vídeňská 800, 140 59 Prague, Czech Republic
2Laboratory for CSF and Neuroimmunology, Topelex Ltd, Central Military Hospital Complex, U Vojenské nemocnice 1200, 162 00 Prague, Czech Republic
3Department of Neurology, 3rd Medical Faculty, Charles University, Šrobárova 50, 100 34 Prague, Czech Republic
4Statistical Unit, Institute for Clinical and Experimental Medicine, Vídeňská 1958/9, 140 21 Prague, Czech Republic

Received 13 February 2013; Revised 23 April 2013; Accepted 21 May 2013

Academic Editor: Shih-Bin Su

Copyright © 2013 Klára Bořecká et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Sobek, P. Adam, M. Koudelková, P. Štourač, and J. Mareš, “The algorithm of CSF examination according to the recommendation of the Committee of CSF and Neuroimmunology of the Czech Neurological Society,” Česká a Slovenská Neurologie, vol. 108, no. 2, pp. 159–163, 2012.
  2. F. Deisenhammer, A. Bartos, R. Egg et al., “Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force,” European Journal of Neurology, vol. 13, no. 9, pp. 913–922, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Adam, L. Táborský, O. Sobek et al., “Cerebrospinal fluid,” Advances in Clinical Chemistry, vol. 36, pp. 1–62, 2001. View at Publisher · View at Google Scholar
  4. K. Felgenhauer, “Laboratory of neurological diseases,” in Clinical Laboratory Diagnostics. Use and Assessment of Clinical Laboratory Results, L. Thomas, Ed., pp. 1308–1326, TH-Books Verlagsgesellschaft mbH, Franfurkt, Germany, 1998.
  5. P. Kelbich, P. Adam, O. Sobek et al., “Basic cerebrospinal fluid test in diagnosing central nervous system involvement,” Neurologie Pro Praxi, vol. 10, no. 5, pp. 285–289, 2009.
  6. P. Kelbich, S. Slavík, J. Jasanská, et al., “Evaluation of the energy relations in the CSF compartment by investigation of selected parameters of the glucose metabolism in the CSF,” Klinicka Biochemie a Metabolismus, vol. 6, no. 27, pp. 213–225, 1998.
  7. O. Sobek, M. Koudelková, and L. Hajduková, “Evaluation of cerebrospinal fluid—current potentials,” Neurologie Pro Praxi, vol. 10, no. 5, pp. 280–284, 2009.
  8. N. T. Huy, N. T. H. Thao, D. T. N. Diep, M. Kikuchi, J. Zamora, and K. Hirayama, “Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis: a systemic review and meta-analysis,” Critical Care, vol. 14, no. 6, article R240, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Sakushima, Y. Hayashino, T. Kawaguchi, J. L. Jackson, and S. Fukuhara, “Diagnostic accuracy of cerebrospinal fluid lactate for differentiating bacterial meningitis from aseptic meningitis: a meta-analysis,” Journal of Infection, vol. 62, no. 4, pp. 255–262, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. O. Hoffman and J. R. Weber, “Pathophysiology and treatment of bacterial meningitis,” Therapeutic Advances in Neurological Disorders, vol. 2, no. 6, pp. 401–412, 2009. View at Publisher · View at Google Scholar
  11. A. H. Abro, A. S. Abdou, A. M. Ustadi, A. A. Saleh, N. J. Younis, and W. F. Doleh, “CSF lactate level: a useful diagnostic tool to differentiate acute bacterial and viral meningitis,” Journal of the Pakistan Medical Association, vol. 59, no. 8, pp. 508–511, 2009. View at Scopus
  12. I. Vengerov, M. V. Nagibina, V. B. Chentsov, T. E. Migmanov, S. A. Menushenkova, and T. N. Molotilova, “Clinical implication of lactate-acidosis in purulent meningitis,” Terapevticheskii Arkhiv, vol. 80, no. 11, pp. 33–36, 2008. View at Scopus
  13. P. Kelbich, A. Hejčl, J. Procházka, E. Hanuljaková, J. Peruthová, and J. Špička, “Cerebrospinal fluid cytology and energy balance as important attributes of cerebrospinal fluid examination,” Klinicka Biochemie a Metabolismus, vol. 20, no. 41, pp. 17–24, 2012.
  14. P. Kelbich, M. Koudelková, H. Machová et al., “Importance of urgent cerebrospinal fluid examination for early diagnosis of central nervous system infections,” Klinická Mikrobiologie a Infekční Lékařství, vol. 13, no. 1, pp. 9–20, 2007.
  15. P. Kelbich, A. Hejčl, J. Procházka et al., “Number of cells in the cerebrospinal fluid, energy relations in the cerebrospinal fluid compartment and intensity of inflammatory response in the central nervous system,” Klinicka Biochemie a Metabolismus, vol. 21, no. 42, pp. 6–12, 2013.
  16. P. Kelbich, M. Šimečková, P. Adam et al., “Findings in Cerebrospinal fluid in patient with bacterial meningitis—case report,” Klinicka Biochemie a Metabolismus, vol. 10, no. 31, pp. 54–68, 2002.
  17. S. Seyfert, V. Kunzmann, N. Schwertfeger, H. C. Koch, and A. Faulstich, “Determinants of lumbar CSF protein concentration,” The Journal of Neurology, vol. 249, no. 8, pp. 1021–1026, 2002.
  18. O. Sobek and P. Adam, “On S. Seyfert, V. Kunzmann, N. Schwertfeger, H. C. Koch, A. Faulstich: determinants of lumbar CSF protein concentration,” Journal of Neurology, vol. 250, no. 3, pp. 371–372, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Reiber, “Dynamics of brain-derived proteins in cerebrospinal fluid,” Clinica Chimica Acta, vol. 310, no. 2, pp. 173–186, 2001.
  20. H. Reiber, E. J. Thompson, G. Grimsley et al., “Quality assurance for cerebrospinal fluid protein analysis: international consensus by an internet-based group discussion,” Clinical Chemistry and Laboratory Medicine, vol. 41, no. 3, pp. 331–337, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. O. Sobek, P. Adam, and J. Svatonova, “Letter to the Editor—comments on published article by F. Deisenhammer et al,” European Journal of Neurology, vol. 14, no. 6, article 1468, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. M. Slauch, “How does the oxidative burst of macrophages kill bacteria? Still an open question,” Molecular Microbiology, vol. 80, no. 3, pp. 580–583, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. H. J. Forman and M. Torres, “Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling,” American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 12, pp. S4–S8, 2002.
  24. K. E. Iles and H. J. Forman, “Macrophage signaling and respiratory burst,” Immunologic Research, vol. 26, no. 1–3, pp. 95–105, 2002. View at Scopus
  25. C. Elbim and G. Lizard, “Flow cytometric investigation of neutrophil oxidative burst and apoptosis in physiological and pathological situations,” Cytometry Part A, vol. 75, no. 6, pp. 475–481, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. J. I. Pagel and E. Deindl, “Disease progression mediated by egr-1 associated signaling in response to oxidative stress,” International Journal of Molecular Sciences, vol. 13, pp. 13104–13117, 2012. View at Publisher · View at Google Scholar
  27. J. P. Tung, J. F. Fraser, P. Wood, and Y. L. Fung, “Respiratory burst function of ovine neutrophils,” BMC Immunology, vol. 10, 2009. View at Publisher · View at Google Scholar
  28. N. Bhattacharyya, A. Pal, S. Patra, A. K. Haldar, S. Roy, and M. Ray, “Activation of macrophages and lymphocytes by methylglyoxal against tumor cells in the host,” International Immunopharmacology, vol. 8, no. 11, pp. 1503–1512, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. J. J. Provencio, X. Fu, A. Siu, P. A. Rasmussen, S. L. Hazen, and R. M. Ransohoff, “CSF neutrophils are implicated in the development of vasospasm in subarachnoid hemorrhage,” Neurocritical Care, vol. 12, no. 2, pp. 244–251, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Fassbender, B. Hodapp, S. Rossol et al., “Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries,” Journal of Neurology Neurosurgery and Psychiatry, vol. 70, no. 4, pp. 534–537, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Procházka, P. Kelbich, A. Hejčl, and P. Vachata, “Cerebrospinal fluid changes in inflammatory affection after subarachnoidal haemorrhage,” Intensive Care Medicine, vol. 35, supplement 1, p. S254, 2009.
  32. H. Machová and P. Kelbich, “Je laboratorní obraz purulentního zánětu při vyšetření likvoru v souvislosti se SAK?” Alergie, vol. 8, no. 4, p. 345, 2006.
  33. J. Tichý, “Subarachnoid haemorrhage—findings in cerebrospinal fluid, in particular the glucose level,” Česka a Slovenska Neurologie a Neurochirurgie, vol. 66, no. 1, pp. 14–19, 2003.
  34. V. Hořejší and J. Bartůňková, Základy Imunologie, Triton, Praha, Czech Republic, 4th edition, 2009.
  35. J. Krejsek and O. Kopecký, Klinická Imunologie, Nucleus HK, 1st edition, 2004.
  36. P. Adam, L. Táborský, O. Sobek, and P. Kelbich, Cytology of Cerebrospinal Fluid, Medica News Publishers, Praha, Czech Republic, 1st edition, 2003.
  37. Y. Xiong, P. L. Peterson, and C. P. Lee, “Alterations in cerebral energy metabolism induced by traumatic brain injury,” Neurological Research, vol. 23, no. 2-3, pp. 129–138, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Kelbich, P. Vachata, M. Sameš et al., “Stálá překvapení v likvorové diagnostice sekundárních purulentních neuroinfekcí u neurochirurgických pacientů,” Alergie, vol. 8, no. 4, p. 345, 2006.